| Business Summary |
| A bio-pharmaceutical company, developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. |
| General Information |
Sturlugata 8
IS-101
Reykjavik,
|
| www.decode.com |
| Industry : Diversified Services |
| Sector: Services |
| Employees: 331 |
| CEO: Dr. Kari Stefansson, M.D |
| Short Interest |
| Current Month (Mil) |
2.75 |
| Previous Month (Mil) |
2.83 |
| Short Interest Ratio (Days) |
5.90 |
| Management Effectiveness |
| Return on Equity |
n.a. |
| Return on Assets |
-88.40 |
| Return on Investments |
243.00 |
| Profitability |
| Gross Margin |
31.90 |
| EBIT Margin |
n.a. |
| Profit Margin |
0.00 |
Connect with TheStreet